Causal relationship between plasma branched-chain amino acids levels and nonalcoholic fatty liver disease: a bidirectional Mendelian randomization study
Open Access
- 19 June 2026
- journal article
- Published by Elsevier in Experimental Gerontology
- Vol. 222, 113210
Abstract
No abstract availableKeywords
Funding Information
- Wuxi Health and Family Planning Commission
This publication has 28 references indexed in Scilit:
- FinnGen provides genetic insights from a well-phenotyped isolated populationNature, 2023
- Effects of serum branched-chain amino acids on nonalcoholic fatty liver disease and subsequent cardiovascular diseaseHepatology International, 2022
- Emerging Roles for Branched-Chain Amino Acid Metabolism in CancerCancer Cell, 2020
- Mendelian RandomizationJAMA, 2017
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median EstimatorGenetic Epidemiology, 2016
- Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatideDiabetes Research and Clinical Practice, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Plasma metabolomic profile in nonalcoholic fatty liver diseaseMetabolism, 2011
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009